Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
198
-
Total 13F shares, excl. options
-
87.1M
-
Shares change
-
-3.64M
-
Total reported value, excl. options
-
$1.02B
-
Value change
-
-$45.4M
-
Put/Call ratio
-
0.97
-
Number of buys
-
80
-
Number of sells
-
-109
-
Price
-
$11.74
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q1 2019
254 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q1 2019.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 198 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87.1M shares
of 106M outstanding shares and own 82.29% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15.8M shares), FEDERATED INVESTORS INC /PA/ (11.2M shares), VANGUARD GROUP INC (10.9M shares), INGALLS & SNYDER LLC (8.37M shares), RENAISSANCE TECHNOLOGIES LLC (5.06M shares), Consonance Capital Management LP (3.75M shares), STATE STREET CORP (3.14M shares), DIMENSIONAL FUND ADVISORS LP (2.31M shares), Invesco Ltd. (2.16M shares), and Bank of New York Mellon Corp (1.28M shares).
This table shows the top 198 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.